Regulation of human dendritic cells by a novel specific nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin

Human Immunology

Volumn 71, Issue 8, 2010, Pages 763-770

  Shinoda, Kazunobu ^a   Nakagawa, Ken ^a   Kosaka, Takeo ^a   Tanaka, Nobuyuki ^a   Maeda, Takahiro ^a   Kono, Hidaka ^a   Mizuno, Ryuichi ^a   Kikuchi, Eiji ^a   Miyajima, Akira ^a   Umezawa, Kazuo ^a   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Immunoregulation; NF B inhibitor

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; DEHYDROXYMETHYLEPOXYQUINOMICIN; HLA DR ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P70; INTERLEUKIN 6; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; DRUG POTENCY; ENDOCYTOSIS; GENETIC TRANSCRIPTION; IMMUNOREGULATION; IMMUNOSTIMULATION; INTRACELLULAR TRANSPORT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; TH1 CELL; UPREGULATION;

ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BENZAMIDES; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXANONES; CYTOKINES; DENDRITIC CELLS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TH1 CELLS; TIME FACTORS;

EID: 77954761223     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.009     Document Type: Article

References (31)

1. Briscoe D.M., Sayegh M.H. A rendezvous before rejection: Where do T cells meet transplant antigens?. Nat Med 2002, 8:220-222.
2. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
3. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998, 188:2175-2180.
4. Ouaaz F., Arron J., Zheng Y., Choi Y., Beg A.A. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002, 16:257-270.
5. McCaffrey P.G., Kim P.K., Valge-Archer V.E., Sen R., Rao A. Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells. Nucleic Acids Res 1994, 22:2134-2142.
6. Meyer S., Kohler N.G., Joly A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett 1997, 413:354-358.
7. Venkataraman L., Burakoff S.J., Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med 1995, 181:1091-1099.
8. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
9. Boumpas D.T., Chrousos G.P., Wilder R.L., Cupps T.R., Balow J.E. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 1993, 119:1198-1208.
10. Tamura K., Fujimura T., Tsutsumi T., Nakamura K., Ogawa T., Atumaru C., et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 1995, 59:1606-1613.
11. Matsumoto N., Ariga A., To-e S., Nakamura H., Agata N., Hirano S., Nakamura H., Agata N., Hirano S., et al. Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C. Bioorg Med Chem Lett 2000, 10:865-869.
12. Ariga A., Namekawa J., Matsumoto N., Inoue J., Umezawa K. Inhibition of tumor necrosis factor-alpha-induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J Biol Chem 2002, 277:24625-24630.
13. Umezawa K. Inhibition of tumor growth by NF-kappaB inhibitors. Cancer Sci 2006, 97:990-995.
14. Suzuki E., Umezawa K. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Biomed Pharmacother 2006, 60:578-586.
15. Renard P., Ernest I., Houbion A., Le Calvez H., Raes M., Remacle J. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 2001, 29:E21. M.
16. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001, 166:4312-4318.
17. Matsumoto G., Namekawa J., Muta M., Nakamura T., Bando H., Tohyama K., et al. Targeting of nuclear factor kappaB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo. Clin Cancer Res 2005, 11:1287-1293.
18. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
19. Epinat J.C., Gilmore T.D. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene 1999, 18:6896-6909.
20. Bonham C.A., Peng L., Liang X., Chen Z., Wang L., Ma L., et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol 2002, 169:3382-3391.
21. Saemann M.D., Kelemen P., Bohmig G.A., Horl W.H., Zlabinger G.J. Hyporesponsiveness in alloreactive T-cells by NF-kappaB inhibitor-treated dendritic cells: Resistance to calcineurin inhibition. Am J Transplant 2004, 4:1448-1458.
22. Zeyda M., Kirsch B.M., Geyeregger R., Stuhlmeier K.M., Zlabinger G.J., Horl W.H., et al. Inhibition of human dendritic cell maturation and function by the novel immunosuppressant FK778. Transplantation 2005, 80:1105-1111.
23. Kikuchi E., Horiguchi Y., Nakashima J., Kuroda K., Oya M., Ohigashi T., et al. Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res 2003, 63:107-110.
24. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5:219-234.
25. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
26. Ziegler-Heitbrock L., Lotzerich M., Schaefer A., Werner T., Frankenberger M., Benkhart E. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J Immunol 2003, 171:285-290.
27. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins twenty-seven and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007, 8:1363-1371.
28. Nakahara T., Uchi H., Urabe K., Chen Q., Furue M., Moroi Y. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int Immunol 2004, 16:1701-1709.
29. Laderach D., Compagno D., Danos O., Vainchenker W., Galy A. Interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol 2003, 171:1750-1757.
30. Miyajima A., Kosaka T., Seta K., Asano T., Umezawa K., Hayakawa M. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 2003, 169:1559-1563.
31. Kosaka T., Miyajima A., Kikuchi E., Horiguchi Y., Umezawa K., Ohigashi T., et al. The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats. Nephron Exp Nephrol 2008, 110:e17.